Non-ownership Filings
| Update on Saphnelo subcutaneous administration | Feb. 03, 2026 |
| Total Voting Rights | Feb. 02, 2026 |
| AstraZeneca agrees obesity and T2D deal with CSPC | Jan. 30, 2026 |
| AstraZeneca invests $15bn in China through 2030 | Jan. 29, 2026 |
| AstraZeneca to complete direct listing on NYSE | Jan. 20, 2026 |
| AZN new Head of Investor Relations Joris Silon | Jan. 08, 2026 |
| Total Voting Rights | Jan. 02, 2026 |
Ownership Update Filings
| Director/PDMR Shareholding | Dec. 22, 2025 |
| Director/PDMR Shareholding | Dec. 19, 2025 |
| Director/PDMR Shareholding | Nov. 14, 2025 |
| Director/PDMR Shareholding | Nov. 10, 2025 |
| Director/PDMR Shareholding | Sep. 25, 2025 |
| Holding(s) in Company | Aug. 28, 2025 |
| Holding(s) in Company | Aug. 26, 2025 |